Chiguru Cancer Care Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 16-07-2024
- Paid Up Capital ₹ 1.80 M
as on 16-07-2024
- Company Age 15 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.88 Cr
as on 16-07-2024
- Satisfied Charges ₹ 6.91 Cr
as on 16-07-2024
- Revenue -0.94%
(FY 2023)
- Profit 24.31%
(FY 2023)
- Ebitda 5.05%
(FY 2023)
- Net Worth 26.60%
(FY 2023)
- Total Assets 224.27%
(FY 2023)
About Chiguru Cancer Care
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.80 M.
The company currently has active open charges totaling ₹9.88 Cr. The company has closed loans amounting to ₹6.91 Cr, as per Ministry of Corporate Affairs (MCA) records.
Yathish Murthy and Ammasandra Sadashivaiah serve as directors at the Company.
- CIN/LLPIN
U85110KA2009PTC050962
- Company No.
050962
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Sep 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chiguru Cancer Care?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yathish Murthy  | Director | 16-Sep-2009 | Current |
| Ammasandra Sadashivaiah | Director | 05-Jan-2013 | Current |
Financial Performance of Chiguru Cancer Care.
Chiguru Cancer Care Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.94% decrease. The company also saw a substantial improvement in profitability, with a 24.31% increase in profit. The company's net worth Soared by an impressive increase of 26.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chiguru Cancer Care?
In 2023, Chiguru Cancer Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Valleylab Cell Therapeutics Private LimitedActive 3 years 2 monthsYathish Murthy and Ammasandra Sadashivaiah are mutual person
- Caryota Lifesciences India Private LimitedActive 13 years 5 months
Ammasandra Sadashivaiah is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 30 Nov 2022 | ₹9.38 Cr | Open |
Reliance Capital Ltd Creation Date: 31 Oct 2009 | ₹5.00 M | Open |
Corporation Bank Creation Date: 05 Aug 2013 | ₹3.56 Cr | Satisfied |
How Many Employees Work at Chiguru Cancer Care?
Unlock and access historical data on people associated with Chiguru Cancer Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chiguru Cancer Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chiguru Cancer Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
